Marca Nominativa depositada no INPI em 16/12/2020 por Roche Diabetes Care GmbH, processo nº 501579260, nas classes 09, 10, 42. Registro em vigor até 16/12/2030.
| Número do processo | 501579260 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 16/12/2020 |
| Data da concessão | 26/04/2022 |
| Vigência até | 16/12/2030 |
| Titular | Roche Diabetes Care GmbH |
| CNPJ/CPF do titular | — |
| UF · País | — · DE |
Computer software and computer hardware for use in the fields of medicine and diagnostics; computer software for use in the field of diabetes; computer software for use with blood glucose monitoring instruments; computer software for use with glucose sensors namely, software for recording, analyzing, reporting and managing patient glucose levels; computer software for recording, analyzing, reporting and managing patient medical information; downloadable software in the nature of a mobile application for use in the electronic transmission of patient medical information.;
Medical apparatus and instruments for use in the field of diabetes; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices, sold therewith; integrated medical examination systems comprising medical devices in the nature of glycemic management and computer software for use in calculating, reviewing, analyzing and displaying patient data.;
Design and development of computer software in the field of healthcare organizations and solutions; platform as a service [PaaS] in the medical field; providing a website featuring resources, namely, non-downloadable software for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; providing on-line, non-downloadable, Internet-based software application for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients; software as a service (SAAS) services featuring software for use in reporting and analyzing the measurement and monitoring of glucose in diabetes patients.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501579260 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.